Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards

This study is examining whether giving magnesium supplements to hospitalized patients with low blood magnesium levels (hypomagnesemia) improves outcomes such as survival, length of hospital stay, and overall wellbeing, compared to the current standard of care which often involves no further treatment after discharge. Low magnesium is commonly found in hospitalized patients and has been associated with higher mortality, but whether correcting it makes a difference is unclear. Adults aged 18 or older admitted to an internal medicine ward with a magnesium level at or below 1.9 mg/dL who can provide consent are eligible, while those with advanced kidney disease, severe diarrhea, critically ill patients, or patients already receiving magnesium are excluded. Participants will receive oral magnesium citrate supplementation for several months and will be followed for clinical outcomes. This summary was prepared to help patients understand the study in plain language.